These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 17960794

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS, Han J, Shim YM, Park J, Kim DH.
    Cancer; 2005 Nov 01; 104(9):1825-33. PubMed ID: 16177988
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 01; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
    Kim DS, Kim MJ, Lee JY, Lee SM, Choi JY, Yoon GS, Na YK, Hong HS, Kim SG, Choi JE, Lee SY, Park JY.
    Mol Carcinog; 2009 Dec 15; 48(12):1109-15. PubMed ID: 19554572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ, Ouyang T, Wan WH, Deng GR.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 15; 29(8):609-13. PubMed ID: 18210882
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
    Kim H, Kwon YM, Kim JS, Han J, Shim YM, Park J, Kim DH.
    Cancer; 2006 Sep 01; 107(5):1042-9. PubMed ID: 16888795
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 01; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 19. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T.
    Clin Cancer Res; 2010 Apr 15; 16(8):2418-26. PubMed ID: 20371677
    [Abstract] [Full Text] [Related]

  • 20. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R.
    Mol Carcinog; 2002 Aug 15; 34(4):187-98. PubMed ID: 12203370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.